Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adverse reactions associated with nefopam

P I Pillans1, D J Woods

  • 1Centre for Adverse Reactions Monitoring, University of Otago Medical School, Dunedin.

The New Zealand Medical Journal
|September 22, 1995
PubMed
Summary

Nefopam, an analgesic, can cause predictable adverse effects like confusion and hallucinations. Healthcare providers should be aware of its contraindications and pharmacology for safe patient use.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thermodynamic temperature assignment to the point of inflection of the melting curve of high-temperature fixed points.

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2016
Same author

Implications of efavirenz for neuropsychiatry: a review.

The International journal of neuroscience·2010
Same author

Transcriptome analysis of the synganglion from the brown dog tick, Rhipicephalus sanguineus.

Insect molecular biology·2009
Same author

Toenails and agranulocytosis.

Internal medicine journal·2007
Same author

Heparin-induced thrombocytopenia: recent experience in a large teaching hospital.

Internal medicine journal·2006
Same author

Concordance between clopidogrel use and prescribing guidelines.

Internal medicine journal·2004

Area of Science:

  • Pharmacovigilance
  • Clinical Pharmacology

Background:

  • Nefopam is an analgesic with a distinct pharmacological profile.
  • Understanding its postmarketing safety profile is crucial for clinical practice.

Observation:

  • A review of 70 spontaneous adverse reaction reports to the New Zealand Centre for Adverse Reactions Monitoring was conducted.
  • Reports spanned a 12-year period, detailing postmarketing experiences with nefopam.

Findings:

  • Most adverse reactions were extensions of nefopam's known pharmacological effects, including confusion, hallucinations, and tachycardia.
  • The review documented the first report of angina associated with nefopam and highlighted seizure risks in susceptible individuals.

Implications:

  • Nefopam can lead to significant adverse effects, necessitating careful consideration of its cautions and contraindications.
  • Improved presentation of nefopam's pharmacology in datasheets is recommended to promote appropriate prescribing and enhance patient safety.

Related Experiment Videos